Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects

Clinical Trial ID NCT04422600

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04422600

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003 3.08
2 Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry 2011 1.07
3 The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicol Teratol 2011 0.97
4 Cannabis and the developing brain: insights from behavior. Eur J Pharmacol 2008 0.95
5 The Ottawa Prenatal Prospective Study (OPPS): methodological issues and findings--it's easy to throw the baby out with the bath water. Life Sci 1995 0.92
6 Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur Child Adolesc Psychiatry 2014 0.92
7 Prenatal cannabis exposure and infant outcomes: overview of studies. Prog Neuropsychopharmacol Biol Psychiatry 2013 0.90
8 Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016 0.82
9 Association between marijuana use and adverse obstetrical and neonatal outcomes. J Perinatol 2015 0.81
10 Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons. Proc Natl Acad Sci U S A 2015 0.78
11 DNA methylation and substance-use risk: a prospective, genome-wide study spanning gestation to adolescence. Transl Psychiatry 2016 0.76
12 Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure. Mol Psychiatry 2016 0.75
13 Data from three prospective longitudinal human cohorts of prenatal marijuana exposure and offspring outcomes from the fetal period through young adulthood. Data Brief 2016 0.75
14 U.S. Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology 2017 0.75
15 Use of Marijuana and Other Substances Among Pregnant and Parenting Women With Substance Use Disorders: Changes in Washington State After Marijuana Legalization. J Stud Alcohol Drugs 2018 0.75
16 Maternal Marijuana Use, Adverse Pregnancy Outcomes and Neonatal Morbidity. Am J Obstet Gynecol 2017 0.75
17 Smokeless tobacco spoils more than the world series. Todays FDA 1990 0.75
Next 100